Literature DB >> 31327290

Cdk5: A main culprit in neurodegeneration.

Krishna Kant Gupta1, Sanjeev Kumar Singh1.   

Abstract

Objectives: Neurodegenerative diseases (NDs) such as Alzheimer Diseases (AD), Parkinson Diseases (PD) are a huge public health problem. The elucidation of their pathophysiological mechanism is one of our greatest challenges. Hyperactive immune system contributes to the pathophysiology of neurological disorders.
Methods: In this review article, we have highlighted the neurodegenerative role of CDK5 and its involvement in Amyloid precursor pathway via Beta secretase enzyme.
Results: All the landmark research reports for CDK5 were considered for this review and its involvement in disrupted autophagy and hyper immune response is the key cause for neurodegeneration.
Conclusion: In conclusion, the present review focus on the pathways associated with Cdk5 and its role in causing neurodegeneration.

Entities:  

Keywords:  Alzheimer Disease; Autophagy; Cdk5; Innate immunity; Neurodegeneration

Mesh:

Substances:

Year:  2019        PMID: 31327290     DOI: 10.1080/00207454.2019.1645142

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  5 in total

Review 1.  CDK5: Key Regulator of Apoptosis and Cell Survival.

Authors:  Rabih Roufayel; Nimer Murshid
Journal:  Biomedicines       Date:  2019-11-06

2.  Protective Effects of Polydatin Against Dementia-Related Disorders.

Authors:  Kim San Tang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

3.  Cdk5 phosphorylation-induced SIRT2 nuclear translocation promotes the death of dopaminergic neurons in Parkinson's disease.

Authors:  Jianguo Yan; Pei Zhang; Jie Tan; Mao Li; Xingfeng Xu; Xiaoyun Shao; Fang Fang; Zhenyou Zou; Yali Zhou; Bo Tian
Journal:  NPJ Parkinsons Dis       Date:  2022-04-20

4.  Integrated Transcriptome Profiling Identifies Prognostic Hub Genes as Therapeutic Targets of Glioblastoma: Evidenced by Bioinformatics Analysis.

Authors:  Chirasmita Nayak; Sanjeev Kumar Singh
Journal:  ACS Omega       Date:  2022-06-22

Review 5.  When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease.

Authors:  Santosh R D'Mello
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.